Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03632213Phase 2Unknown
Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI
Morquio A SyndromeMorquio SyndromeMorquio Syndrome A+6 more
PrincipalinvestigatorStart date: 2018-11-07

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Guilherme Baldo, PhD

Hospital de Clinicas de Porto Algre

Very Similar
1 trials

Shared therapeutic areas:

Morquio A SyndromeMucopolysaccharidosis IVMucopolysaccharidosis Type IV A+5 more

Worked with same sponsors:

Hospital de Clinicas de Porto AlegreThe Isaac Foundation
Collaborated on 1 trial
Similarity Score84%

Celeste Decker, MD

BioMarin Pharmaceutical

Related
4 trials

Shared therapeutic areas:

Morquio A SyndromeMucopolysaccharidosis Type IV AMucopolysaccharidosis VI
Similarity Score11%

Debra Lounsbury

BioMarin Pharmaceutical

Related
4 trials

Shared therapeutic areas:

Mucopolysaccharidosis Type IV AMorquio A SyndromeMucopolysaccharidosis IV A
Similarity Score11%

Chester B. Whitley, M.D., Ph.D.

University of Minnesota

Related
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis IVMucopolysaccharidosis VI
Similarity Score8%

Tippi C MacKenzie, MD

University of California, San Francisco

Related
2 trials

Shared therapeutic areas:

Mucopolysaccharidosis IV AMucopolysaccharidosis VI
Similarity Score8%

Lynda E Polgreen, MD, MS

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Related
2 trials

Shared therapeutic areas:

MucopolysaccharidosesMucopolysaccharidosis VI
Similarity Score8%

Ashley Schneider

University of Minnesota

Related
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis IVMucopolysaccharidosis VI
Similarity Score8%

Melissa Wasserstein, MD

Albert Einstein College of Medicine

Related
2 trials

Shared therapeutic areas:

Mucopolysaccharidosis IV AMucopolysaccharidosis VI
Similarity Score8%

Paul Harmatz, M.D.

Oakland Children's Hospital

Related
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis IVMucopolysaccharidosis VI
Similarity Score8%

Heather Lau, M.D.

New York University

Related
1 trials

Shared therapeutic areas:

Mucopolysaccharidosis IVMucopolysaccharidosis VI
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03632213Phase 2PrincipalInvestigator

Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI

Morquio A SyndromeMorquio SyndromeMorquio Syndrome A+6 more
Unknown

All 1 trials loaded